| |
STIRLING PRODUCTS LIMITED Company Summary |
|
 Stirling Products is developing patented animal growth agents that increase meat production, therefore improving the production efficiency of livestock animals, while decreasing fat accumulation for the benefit of consumers. The Stirling growth agents are under development for swine, poultry, cattle and sheep for global markets and are being positioned to take a major role in reducing the global use of antibiotics and steroid hormones in livestock. Stirling is also developing veterinary medications for heaves in horses through its joint venture in Europe (Pulmovet ApS, www.pulmovet.com) and an obesity treatment in companion animals.
Stirling Products recently acquired a Canadian company Progressive BioActives Incorporated (PBI) under its North American subsidiary, Stirling Products NA Inc. PBI is part of the Bioscience cluster established on located Prince Edward Island, Canada. PBI's lead product ProVale, is the latest high purity beta glucan extract that has been designed as an alternative tool for sustainable livestock management in face of increasing viral disease challenges where antibiotics have no or limited application. ProVale is available for targeted applications in swine, poultry and farmed aquaculture with a future focus on further developing applications for companion animals (e.g. horses, dogs, cats and reptiles). |
|
|
|
 Dr Calvin London B.Sc. (Hon.), M.Sc., Ph.D., ASM
Managing Director
Dr London has over twenty-five years international experience in the pharmaceutical, biological and biotechnology industry, specialising in technical development, regulatory and quality management at an executive level. He has expertise in the manufacturing requirements of complex pharmaceutical products (SVP, LVP and cytotoxic drug products), non-sterile prescription drugs, devices and diagnostics.
|
|
|
|
|
 |
Headquarters |
Level 11, The BGC Centre |
 |
| |
|
28 The Esplanade |
|
| |
|
PERTH WA 6000 |
|
| |
|
Australia |
|
|
Telephone |
+61 8 9480 1480 |
|
|
Fax |
+61 8 9226 4144 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
1997/07/24 |
|
|
Homepage |
www.stirlingproducts.net |
|
| |
|
|
|
| Stock Exchange | Stock Code |  ASX:STI | STI | | | ZOBEX | TPR | | | | | | | |
|
| |
NEWS |
 |
|
|  Stirling Products (ASX:STI) Signs First Product For Companion Animals (AUG 14, 2008) | | Stirling Products (ASX:STI) Gets Australian Patent For Heaves In Horses (JULY 28, 2008) | | Stirling Products (ASX:STI) Announce Provale(tm) Effective At Inhibiting Loma Infection In Rainbow Trout (JULY 15, 2008) | | Stirling Products (ASX:STI) Signs Term Sheet For Novel Insecticide (JUNE 16, 2008) | | Stirling Products (ASX:STI) Launches Companion Animal Health Initiative At BIO2008 International Convention (JUNE 13, 2008) | | Stirling Products (ASX:STI) North America Gets Performance Milestone From Global Animal Pharma Company (JUNE 10, 2008) | | Stirling Products (ASX:STI) Signs With Aquience For Companion Animal Product - PetQuench (JUNE 4, 2008) | | Stirling Products (ASX:STI) North America Signs Supply Agreement For Beta Glucan Provale(TM) (MAY 30, 2008) | | Stirling Products (ASX:STI) South African Regulatory Registration Process For R-salbutamol Progresses (MAY 28, 2008) | | Stirling Products (ASX:STI) North America Starts Second Phase Of Manufacturing Scale-Up (MAR 26, 2008) | | Stirling Products (ASX:STI) Offers Provale To Canadian Distribution Claude Levesque Inc. (MAR 18, 2008) | | Stirling Products (ASX:STI) Signs UK Agreement For Equine Respiratory Disorder Detection (MAR 10, 2008) | | Stirling Products (ASX:STI) Signs Licensing Rights For Omega-3 Meat Enhancement Technology (MAR 6, 2008) | | Stirling Products (ASX:STI) Trials ProVale With US-Based Aqua Bounty Technologies In Chilean Salmon Market (FEB 5, 2008) | | Stirling Products (ASX: STI) Gets Canadian Food Inspection Agency Registration Approval For Provale (JAN 30, 2008) | | Stirling Products (ASX:STI) Gets Approval To Register R-SALBUTAMOL Under Act 36 In South Africa (JAN 24, 2008) | | Stirling Products Limited (ASX: STI) Announce Placement of 42.77 Million Shares (JAN 10, 2008) | | Stirling Products (ASX:STI) Signs Material Transfer Agreement with Pharmswell in Korea (DEC 12, 2007) | | Stirling Products North America Completes First Phase Of Manufacturing Scale-Up (DEC 5, 2007) |
|
|
|
|
